NCT00227227View on ClinicalTrials.gov

Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

CompletedOBSERVATIONAL

Enrollment

750

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

June 30, 2007

Conditions

Ankylosing Spondylitis

Trial Locations (1)

10719

Berlin

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00227227 - Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter